ORGO - Organogenesis Holdings Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
249,935
193,449
0
0
Cost of Revenue
73,067
68,808
4,592
209
Gross Profit
176,868
124,641
-4,592
-209
Operating Expenses
Research Development
14,250
10,742
-
-
Selling General and Administrative
194,803
161,961
-
-
Total Operating Expenses
209,053
172,703
-
209
Operating Income or Loss
-32,185
-48,062
-4,592
-209
Interest Expense
-
10,853
-
-
Total Other Income/Expenses Net
-3,966
-5,896
-
0
Income Before Tax
-45,201
-64,747
-2,094
-209
Income Tax Expense
110
84
-
-
Income from Continuing Operations
-45,311
-64,831
-2,094
-209
Net Income
-45,311
-64,831
-2,094
-209
Net Income available to common shareholders
-45,956
-64,831
-4,436
-209
Reported EPS
Basic
-
-0.94
-0.48
-0.03
Diluted
-
-0.94
-0.48
-0.03
Weighted average shares outstanding
Basic
-
69,318
9,335
7,920
Diluted
-
69,318
9,335
7,920
EBITDA
-
-46,916
-4,592
-209